# Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia

> **NCT05864885** · PHASE1 · UNKNOWN · sponsor: **Aneira Pharma, Inc.** · enrollment: 14 (estimated)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** Minoxidil

## Key facts

- **NCT ID:** NCT05864885
- **Lead sponsor:** Aneira Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-09
- **Primary completion:** 2023-07-17
- **Final completion:** 2023-07-17
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2023-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05864885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05864885, "Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05864885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*